pyrazines has been researched along with Becker Muscular Dystrophy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosio, CE; Araujo, KP; Belizario, JE; Bonuccelli, G; Duarte, CN; Feder, D; Gaiad, TP; Lisanti, MP; Miglino, MA; Moreira, DF | 1 |
| Assereto, S; Bonetto, A; Bonuccelli, G; Bruno, C; Cilli, M; Gazzerro, E; Lisanti, MP; Minetti, C; Pistorio, A; Scarfì, S; Sotgia, F; Zara, F | 1 |
| Bonuccelli, G; Capozza, F; Gazzerro, E; Lisanti, MP; Minetti, C; Sotgia, F | 1 |
3 other study(ies) available for pyrazines and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs.
Topics: Animals; Boronic Acids; Bortezomib; Chymotrypsin; Collagen; Dogs; Dystroglycans; Dystrophin-Associated Protein Complex; Gene Expression; Immunohistochemistry; Inflammation; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Proteasome Endopeptidase Complex; Pyrazines | 2013 |
Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies.
Topics: Animals; Boronic Acids; Bortezomib; Disease Models, Animal; Dystroglycans; Evans Blue; Gene Expression Regulation; Glycoproteins; Mice; Mice, Inbred C57BL; Muscular Dystrophy, Duchenne; Mutation; Proteasome Inhibitors; Pyrazines; Sarcoglycans; Ubiquitin | 2010 |
Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice.
Topics: Animals; Boronic Acids; Bortezomib; Dipeptides; Dystrophin; Dystrophin-Associated Proteins; Male; Mice; Mice, Inbred mdx; Microscopy, Fluorescence; Muscle, Skeletal; Muscular Dystrophy, Duchenne; NF-kappa B; Protease Inhibitors; Pyrazines | 2007 |